About us »  
  · Management  
  · SAB  
 


ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These innovative devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.

Company Snapshot
  Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;
  Developed the first ever vascular stapling technology for stapling synthetic grafts to the aorta
  Developed novel endovascular devices for EVAR and SFA procedures
  Proof of concept of the technology obtained:
    3 pilot human cases with >36 mo follow-up;
    10 patient EU trial completed in Germany;
  CE mark for the 1-st product (Stapler for Open Aortic Surgery) anticipated in January 2008

Management - Board of Directors
  SAB - Scientific Advisory Board

© 2007 ES Vascular Ltd.